Clinical Trials
3
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)Quantitating the Impact of Plerixafor
Phase 1
- Conditions
- Transplants and Implants
- Interventions
- First Posted Date
- 2015-08-13
- Last Posted Date
- 2020-06-30
- Lead Sponsor
- E. Steve Woodle
- Target Recruit Count
- 12
- Registration Number
- NCT02522572
- Locations
- 🇺🇸
The Christ Hospital, Cincinnati, Ohio, United States
🇺🇸University of Cincinnati, Cincinnati, Ohio, United States
Belimumab Impacting Transplant Eligibility
Phase 1
Completed
- Conditions
- Renal Transplant Rejection
- Interventions
- First Posted Date
- 2015-07-16
- Last Posted Date
- 2019-04-22
- Lead Sponsor
- E. Steve Woodle
- Target Recruit Count
- 11
- Registration Number
- NCT02500251
- Locations
- 🇺🇸
The Christ Hospital, Cincinnati, Ohio, United States
🇺🇸University of Cincinnati, Cincinnati, Ohio, United States
B-Cell Targeted Carfilzomib Desensitization
- First Posted Date
- 2015-05-13
- Last Posted Date
- 2020-06-30
- Lead Sponsor
- E. Steve Woodle
- Target Recruit Count
- 32
- Registration Number
- NCT02442648
- Locations
- 🇺🇸
The Christ Hospital, Cincinnati, Ohio, United States
🇺🇸University of Cincinnati, Cincinnati, Ohio, United States
News
No news found